EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ewing Sarcoma
- Carcinoma
- Clear Cell Sarcoma
- Desmoplastic Small Round Cell Tumor
- Germ Cell Tumor
- Synovial Sarcoma
- Wilm's Tumor
- Hepatoblastoma
- Soft Tissue Sarcoma
- Malignant Peripheral Nerve Sheath Tumors
- Rhabdoid Tumor
- Rhabdomyosarcoma
- Neuroblastoma
- Osteosarcoma
- Pediatric Solid Tumor
- Retinoblastoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 1 years and 30 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03618381
- Collaborators
- Not Provided
- Investigators
- Study Chair: Katie Albert, MD Seattle Children's Hospital